Germany takes 300 mln eur stake in vaccine developer CureVac
June 15, 2020 at 07:15 AM EDT
Germany will take a stake of about 23% in unlisted biotech firm CureVac by backing a 300 million euro ($337 million) capital increase to fund the company's further development of a COVID-19 vaccine.
